<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876822</url>
  </required_header>
  <id_info>
    <org_study_id>2016-2193</org_study_id>
    <nct_id>NCT02876822</nct_id>
  </id_info>
  <brief_title>High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation</brief_title>
  <official_title>Safety and Efficacy of Single, High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy and safety of high dose vitamin D therapy&#xD;
      among HSCT patients in a tiered, step-wise manner (step one/two) in order to define treatment&#xD;
      doses capable of providing vitamin D sufficiency.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency is common in childhood and has been associated with increased incidence&#xD;
      of graft versus host disease (GVHD) and decreased survival in patients undergoing&#xD;
      hematopoietic stem cell transplantation (HSCT). Recently, quality improvement efforts to&#xD;
      correct serum vitamin D levels among inpatients at CCHMC who have already received HSCT and&#xD;
      who were vitamin D deficient suggest that current recommended doses of vitamin D are&#xD;
      inadequate to treat vitamin D deficiency. Possible hindrances to vitamin D treatment in the&#xD;
      HSCT population include malabsorption related to gut GVHD, mucositis, increased requirement&#xD;
      for calcium and/or vitamin D, kidney disease, liver disease, and infection. Single, high dose&#xD;
      vitamin D treatment (stoss-therapy) has been utilized effectively to treat rickets and other&#xD;
      chronic illnesses such as cystic fibrosis in children. The investigators hypothesize that&#xD;
      stoss-therapy provided orally prior to transplantation will result in rapid and sustained&#xD;
      correction of vitamin D deficiency in children who require HSCT. The investigators propose to&#xD;
      test the efficacy and safety of high dose vitamin D therapy among HSCT patients in a tiered,&#xD;
      step-wise manner (step one/two) in order to define treatment doses capable of providing&#xD;
      vitamin D sufficiency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Step 1 enrollment complete.&#xD;
  </why_stopped>
  <start_date type="Actual">August 26, 2016</start_date>
  <completion_date type="Actual">May 1, 2017</completion_date>
  <primary_completion_date type="Actual">March 16, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum 25OHD level</measure>
    <time_frame>Weekly for 8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enrolled subjects will receive one observed oral vitamin D dose (based on current vitamin D status and rounded to the nearest 5000IU) within 2 weeks prior to their HSCT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Step 1: Patients who are preparing for HSCT, 25OHD level (&lt;50 ng/mL), and no prior&#xD;
             history of HSCT.&#xD;
&#xD;
          -  Step 2: Patients who are preparing for HSCT 25OHD level (&lt;50 ng/mL).&#xD;
&#xD;
        Exclusion Criteria (both Step 1 and Step 2):&#xD;
&#xD;
          -  Patients with history of pathologic fractures,&#xD;
&#xD;
          -  uncorrected hypocalcemia or hypophosphatemia,&#xD;
&#xD;
          -  known history of nephrocalcinosis or nephrolithiasis,&#xD;
&#xD;
          -  current granulomatous disease,&#xD;
&#xD;
          -  those currently in ICU.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Howell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Children's Hosptial Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229-3039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>August 18, 2020</last_update_submitted>
  <last_update_submitted_qc>August 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

